Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Ranibizumab SR by F. Hoffmann-La Roche for Diabetic Macular Edema: Likelihood of Approval
Ranibizumab SR is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Diabetic Macular Edema. According...
Data Insights
Ranibizumab SR by F. Hoffmann-La Roche for Diabetic Retinopathy: Likelihood of Approval
Ranibizumab SR is under clinical development by F. Hoffmann-La Roche and currently in Phase III for Diabetic Retinopathy. According to...